Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial. [electronic resource]
Producer: 20080715Description: 211-6 p. digitalISSN:- 1099-1077
- Adult
- Antipsychotic Agents -- administration & dosage
- Benzodiazepines -- administration & dosage
- Body Mass Index
- Chemistry, Pharmaceutical
- Chronic Disease
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Olanzapine
- Overweight -- complications
- Prospective Studies
- Psychotic Disorders -- complications
- Schizophrenia -- complications
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.